Ventfort dosing & administration
Vascular peptide bioregulator complex derived from bovine aorta containing ultrashort peptides (including KED sequence) that normalize vascular endothelial function, reduce total cholesterol by up to 30% in clinical studies, and restore arterial elasticity through epigenetic regulation of extracellular matrix remodeling genes in aging blood vessels
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Dosing
How much do I take?
Oral administration: Taken by mouth as a capsule, tablet, or liquid.
Bioavailability Varies by compound — many peptides are largely broken down in the gut, so little reaches the blood intact; some small molecules absorb well.
2 documented dose levels — separate regimens, not a titration schedule
1 capsule (10 mg) once daily
Frequency
Once daily before meals
Duration
10-day initial course
Khavinson A-3 vascular bioregulator (Ventfort); each capsule contains 10 mg peptide complex from vascular tissue [6]. Dietary-supplement form; research/wellness use.
2 capsules (20 mg) daily
Frequency
Once or twice daily before meals
Duration
10–20 day course
Standard daily dose (20 mg/day); courses typically repeated every 6 months [6]. Sublingual enteric-coated capsules used for buccal absorption.
Timing
Best time to take
Take Ventfort at the same time each day for consistent blood levels. Morning dosing with breakfast is often preferred, but follow your healthcare provider's specific instructions.
With food?
Ventfort can typically be taken with or without food. Taking it with a light meal may help reduce any GI discomfort. Avoid taking with grapefruit juice or high-fat meals unless specifically directed.
If stacking
Ventfort should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
Adjusting your dose
Increase if
- You've tolerated the current dose for the recommended period without significant side effects
- Therapeutic goals haven't been met at the current dose level
- Your healthcare provider recommends dose escalation based on your response
- Lab work or clinical assessments support a higher dose
Decrease if
- Side effects are bothersome or impacting daily life despite management strategies
- You experience any signs of an adverse reaction
- Lab results indicate the need for dose reduction
- Your healthcare provider recommends a lower dose based on your response
Signs of right dose
- Therapeutic goals being met with minimal side effects
- Stable and consistent response to treatment
- Lab values or clinical markers trending in the right direction
- Good tolerance with manageable or absent side effects
Administration
How do I use it?
Reconstitution
What you need
Injection
Route
Ventfort is administered Sublingual (enteric-coated capsules)—no injection required
Best sites
Storage
Before reconstitution
Store Ventfort in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.
After reconstitution
Once reconstituted, Ventfort should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.
Signs of degradation — discard the vial
Sample daily schedule
As prescribed (once daily)
As prescribed by your healthcare provider injection
Site: Sublingual (enteric-coated capsules)—rotate sites if applicable
Maintain a consistent schedule for optimal results with Ventfort. Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.
Safety
Is it safe?
Side effects
Commonly reported: Injection site reaction, Mild fatigue, Mild headache, Mild blood pressure fluctuation
Less common: Mild dizziness
Stop and seek help if
- Severe or worsening side effects that don't improve with dose adjustment or supportive care
- Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
- Your healthcare provider recommends discontinuation based on your clinical response
- Development of any new medical condition that may be contraindicated with Ventfort
- Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
- Abnormal lab results or clinical markers that suggest adverse effects
Ventfort should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
Flagged pairings
- Anticoagulant medications (warfarin, heparin) without medical supervision — potential interaction with vascular remodeling effects — Use with caution—discuss with your healthcare provider.
- Potent vasodilators at therapeutic doses without monitoring — additive hypotensive effects during vascular normalization period — Use with caution—discuss with your healthcare provider.
- Other vascular-active supplements at high doses simultaneously — risk of excessive vascular modulation — Use with caution—discuss with your healthcare provider.
Published research
What the studies show
Kozlov KL, Bolotov II, Linkova NS, et al. · 2016
Ventfort peptide supports joint cartilage repair and mobility.
Kitachev KV, Sazonov AB, Kozlov KL, et al. · 2014
Research (2014) on ventfort contributes important scientific knowledge about its biological and pharmacological properties.
Khavinson VK, Linkova NS, Ashapkin VV · 2023
Vilon peptide (KE) regulates longevity genes by activating SIRT1 and suppressing aging-related PARP1/PARP2, with anti-aging effects mediated through DNA binding.
Khavinson VK, Popovich IG, Linkova NS, et al. · 2021
Research (2021) on ventfort contributes important scientific knowledge about its biological and pharmacological properties.
Khavinson VK, Linkova NS, Pronyaeva VE · 2022
Research confirms testagen's role in supporting male reproductive health.
Firma Vita / St. Petersburg Institute of Bioregulation and Gerontology · 2024
Head to head
Ventfort compared
Want the full picture?
The complete Ventfort research profile: mechanism of action, clinical studies, effectiveness timeline, and FAQ.